Rovida Advisors’s Merck MRK Stock Holding History

Rovida Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-451,500	Closed	-$34.6M	–	39
2021 Q4	$34.6M	Hold	451,500	–	–	1.55%	25
2021 Q3	$33.9M	Hold	451,500	–	–	1.44%	25
2021 Q2	$35.1M	Sell	451,500 -21,672	-5%	-$1.61M	1.52%	25
2021 Q1	$34.8M	Hold	473,172	–	–	1.63%	23
2020 Q4	$36.9M	Hold	473,172	–	–	2.17%	17
2020 Q3	$37.4M	Hold	473,172	–	–	2.6%	13
2020 Q2	$34.9M	Buy	+473,172	New	+$35.6M	3.36%	10
2020 Q1	–	Sell	-332,216	Closed	-$28.8M	–	46
2019 Q4	$28.8M	Hold	332,216	–	–	1.53%	24
2019 Q3	$26.7M	Hold	332,216	–	–	1.58%	21
2019 Q2	$26.6M	Hold	332,216	–	–	1.56%	25
2019 Q1	$26.4M	Hold	332,216	–	–	1.79%	21
2018 Q4	$24.2M	Hold	332,216	–	–	2.01%	21
2018 Q3	$22.5M	Hold	332,216	–	–	1.64%	22
2018 Q2	$19.2M	Hold	332,216	–	–	1.58%	23
2018 Q1	$17.3M	Hold	332,216	–	–	1.62%	20
2017 Q4	$17.9M	Hold	332,216	–	–	1.87%	19
2017 Q3	$20.3M	Hold	332,216	–	–	2.15%	21
2017 Q2	$20.3M	Hold	332,216	–	–	2.8%	18
2017 Q1	$20.1M	Hold	332,216	–	–	3.44%	14
2016 Q4	$18.7M	Buy	+332,216	New	+$19.4M	4.15%	11

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Rovida Advisors's MRK Position: Q1 2022 in Review

Rovida Advisors sold out of Merck (MRK) in Q1 2022, closing a stake of 451,500 shares — an estimated $34.6M sold.

Rovida Advisors first reported a position in MRK in Q4 2016 and held it in 20 quarters. The position peaked at $37.4M in Q3 2020. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Rovida Advisors reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
Rovida Advisors sold 451,500 Merck shares in Q1 2022, an estimated $34.6M.
Rovida Advisors first reported a position in Merck in Q4 2016 and held it in 20 quarters.
Rovida Advisors's Merck position peaked at $37.4M in Q3 2020.
2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Rovida Advisors's 13F filing for Q1 2022, filed 10 May 2022.